Diseases
Explore disease pages that summarize symptoms, diagnostic context, and related care topics.
All diseases (73,990)
T460X2S
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela
T460X3A
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
T460X3D
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter
T460X3S
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela
T460X4A
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
T460X4D
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter
T460X4S
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela
T460X5A
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T460X5D
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
T460X5S
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
T460X6A
Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T460X6D
Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
T460X6S
Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela
T461X1A
Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter
T461X1D
Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter
T461X1S
Poisoning by calcium-channel blockers, accidental (unintentional), sequela
T461X2A
Poisoning by calcium-channel blockers, intentional self-harm, initial encounter
T461X2D
Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter
T461X2S
Poisoning by calcium-channel blockers, intentional self-harm, sequela
T461X3A
Poisoning by calcium-channel blockers, assault, initial encounter
T461X3D
Poisoning by calcium-channel blockers, assault, subsequent encounter
T461X3S
Poisoning by calcium-channel blockers, assault, sequela
T461X4A
Poisoning by calcium-channel blockers, undetermined, initial encounter
T461X4D
Poisoning by calcium-channel blockers, undetermined, subsequent encounter
T461X4S
Poisoning by calcium-channel blockers, undetermined, sequela
T461X5A
Adverse effect of calcium-channel blockers, initial encounter
T461X5D
Adverse effect of calcium-channel blockers, subsequent encounter
T461X5S
Adverse effect of calcium-channel blockers, sequela
T461X6A
Underdosing of calcium-channel blockers, initial encounter
T461X6D
Underdosing of calcium-channel blockers, subsequent encounter
T461X6S
Underdosing of calcium-channel blockers, sequela
T462X1A
Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
T462X1D
Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter
T462X1S
Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela
T462X2A
Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter
T462X2D
Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter
T462X2S
Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela
T462X3A
Poisoning by other antidysrhythmic drugs, assault, initial encounter
T462X3D
Poisoning by other antidysrhythmic drugs, assault, subsequent encounter
T462X3S
Poisoning by other antidysrhythmic drugs, assault, sequela
T462X4A
Poisoning by other antidysrhythmic drugs, undetermined, initial encounter
T462X4D
Poisoning by other antidysrhythmic drugs, undetermined, subsequent encounter
T462X4S
Poisoning by other antidysrhythmic drugs, undetermined, sequela
T462X5A
Adverse effect of other antidysrhythmic drugs, initial encounter
T462X5D
Adverse effect of other antidysrhythmic drugs, subsequent encounter
T462X5S
Adverse effect of other antidysrhythmic drugs, sequela
T462X6A
Underdosing of other antidysrhythmic drugs, initial encounter
T462X6D
Underdosing of other antidysrhythmic drugs, subsequent encounter
T462X6S
Underdosing of other antidysrhythmic drugs, sequela
T463X1A
Poisoning by coronary vasodilators, accidental (unintentional), initial encounter
T463X1D
Poisoning by coronary vasodilators, accidental (unintentional), subsequent encounter
T463X1S
Poisoning by coronary vasodilators, accidental (unintentional), sequela
T463X2A
Poisoning by coronary vasodilators, intentional self-harm, initial encounter
T463X2D
Poisoning by coronary vasodilators, intentional self-harm, subsequent encounter
T463X2S
Poisoning by coronary vasodilators, intentional self-harm, sequela
T463X3A
Poisoning by coronary vasodilators, assault, initial encounter
T463X3D
Poisoning by coronary vasodilators, assault, subsequent encounter
T463X3S
Poisoning by coronary vasodilators, assault, sequela
T463X4A
Poisoning by coronary vasodilators, undetermined, initial encounter
T463X4D
Poisoning by coronary vasodilators, undetermined, subsequent encounter
T463X4S
Poisoning by coronary vasodilators, undetermined, sequela
T463X5A
Adverse effect of coronary vasodilators, initial encounter
T463X5D
Adverse effect of coronary vasodilators, subsequent encounter
T463X5S
Adverse effect of coronary vasodilators, sequela
T463X6A
Underdosing of coronary vasodilators, initial encounter
T463X6D
Underdosing of coronary vasodilators, subsequent encounter
T463X6S
Underdosing of coronary vasodilators, sequela
T464X1A
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
T464X1D
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter
T464X1S
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela
T464X2A
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
T464X2D
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter
T464X2S
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela
T464X3A
Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter
T464X3D
Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter
T464X3S
Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela
T464X4A
Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter
T464X4D
Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter
T464X4S
Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela
T464X5A
Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
T464X5D
Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
T464X5S
Adverse effect of angiotensin-converting-enzyme inhibitors, sequela
T464X6A
Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter
T464X6D
Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter
T464X6S
Underdosing of angiotensin-converting-enzyme inhibitors, sequela
T465X1A
Poisoning by other antihypertensive drugs, accidental (unintentional), initial encounter
T465X1D
Poisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter
T465X1S
Poisoning by other antihypertensive drugs, accidental (unintentional), sequela
T465X2A
Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter
T465X2D
Poisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter
T465X2S
Poisoning by other antihypertensive drugs, intentional self-harm, sequela
T465X3A
Poisoning by other antihypertensive drugs, assault, initial encounter
T465X3D
Poisoning by other antihypertensive drugs, assault, subsequent encounter
T465X3S
Poisoning by other antihypertensive drugs, assault, sequela
T465X4A
Poisoning by other antihypertensive drugs, undetermined, initial encounter
T465X4D
Poisoning by other antihypertensive drugs, undetermined, subsequent encounter
T465X4S
Poisoning by other antihypertensive drugs, undetermined, sequela
T465X5A
Adverse effect of other antihypertensive drugs, initial encounter
T465X5D
Adverse effect of other antihypertensive drugs, subsequent encounter
T465X5S
Adverse effect of other antihypertensive drugs, sequela